Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » ASK2-4U: OHRP director explains shift on central IRBs

    ASK2-4U: OHRP director explains shift on central IRBs

    August 1, 2010
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Products

    ASK2-4U: OHRP director explains shift on central IRBs | Single Article

    OHRP correspondence on central IRBs | Single Article

    OHRP move might increase trend of research sites using centralized IRBs | Single Article

    ASK2-4U

    OHRP director explains shift on central IRBs

    'Use of a central IRB can be a very good thing'

    The Office for Human Research Protections (OHRP) in Washington, DC, is indicating to research institutions that the agency favors the use of centralized IRBs for multisite studies. Recently, the agency published a letter it had written to a North Carolina hospital system about the use of central IRBs. IRB Advisor asked OHRP Director Jerry A. Menikoff, MD, JD, about this change. Some of his answer is contained in this "Ask2-4U" below:

    IRB Advisor: Who is responsible if an external IRB has a noncompliance issue when reviewing a research site's study?

    Menikoff: The bottom line is that if something inappropriate happens in the study due to an outside IRB, whether it's a central or some other IRB doing something wrong, and we take a compliance action related to that, we will certainly make it clear in our findings that the fault was due to the IRB and not to the people in the institution. It's a question of making it as clear as possible so everybody understands who really was at fault.

    In that one example of the letter to the University of Oklahoma, there was one NCI [National Cancer Institute] central IRB that reviewed the study, and Oklahoma was one of the sites. Oklahoma's IRB reviewed the study, and its IRB did not change some of the consent provisions that were approved by the central IRB. The complainant complained about some provisions of the consent form.

    We made it clear that Oklahoma wasn't doing anything worse than the other 100 sites using the consent form, which was vetted by the central IRB. We think some of this is common sense. As far as liability goes, [it pertains to] whoever does something wrong.

    IRB Advisor: Is there any other message about central IRBs that you'd like to send to research sites?

    Menikoff: I don't know the message is any different than what the letter is trying to get out. That is why when we received this query [from Carolinas Medical Center in Charlotte, NC] we viewed it as a good opportunity to make our response public. We do very much think the use of a central IRB can be a very good thing. We do encourage their use, and I want to clarify on this issue there's a great deal of harmony between FDA's and OHRP's viewpoints. Both entities are very much in favor of this.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    IRB Advisor

    View PDF
    IRB Advisor 2010-08-01
    August 1, 2010

    Table Of Contents

    OHRP move might increase trend of research sites using centralized IRBs

    ASK2-4U: OHRP director explains shift on central IRBs

    OHRP correspondence on central IRBs

    Drama queens (and kings) help IRB training

    What are four key areas to teach in informed consent?

    Biobank uses opt-out approach to gathering blood samples

    Survey shows QI projects do get some oversight

    Informed consent when the victim is a black male

    Begin Test
    Buy this Issue/Course

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events

    Free Email Newsletters

    All Fields Required

    E-Newsletter Options
    • Accreditation Council for Continuing Medical Education
    • American Nurses Credentialing Center
    • American College of Emergency Physician
    • American Board of Internal Medicine: Maintenance of Certification
    • California Board of Registered Nursing
    • Commission for Case Manager Certification
    • American Academy of Pediatrics
    • American Osteopathic Association
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2019 Relias. All rights reserved.

    Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing